- Record sales: Sales volume €7.4 billion, up by 52 percent
- Significant improvement: Adjusted EBIT increased by
58 percent to €416 million; adjusted EBITDA rose by
56 percent to €460 million
- Global Team: Number of employees increases to almost 9,000
- Success in all business segments: Incoming orders amounted to
around €7.6 billion, order backlog at €6.8 billion
- Positive outlook: Growth strategy "Pathway to Ten" and future
agenda "Next Level" aiming at a sales level of €10 billion in
2027
STUTTGART, Germany,
March 28, 2023 /PRNewswire/ --
Exyte GmbH (Exyte), a global leader in the design, engineering,
and delivery of high-tech facilities, has again reached record
level annual results in 2022.
Last year, Exyte achieved record sales of €7.4 billion
(2021: €4.9 billion), an increase of 52 percent
year-on-year based on strong growth in all business segments. The
order intake amounted to €7.6 billion. The order backlog
reached €6.8 billion. Exyte continued to improve its profitability
with an adjusted EBITDA of €460 million (2021:
€294 million) and an adjusted EBIT of €416 million (2021:
€263 million). The adjusted EBITDA margin was 6.2 percent
(2021: 6.0 percent), while the adjusted EBIT margin reached
5.6 percent (2021: 5.4 percent). Both figures increased
by 0.2 percentage points year-on-year.
"2022 was an exceptional and very successful year for Exyte. We
achieved again record results. Business development exceeded our
expectations. In view of the ongoing macroeconomic headwinds this
is an outstanding performance we are proud of. Essential to our
success are our dedicated employees who support our clients around
the globe with their ongoing commitment, great passion, and
know-how," says Dr. Wolfgang Büchele, CEO of Exyte.
"In 2022 we overachieved our ambitious forecasts for the
important key figures sales, adjusted EBITDA and adjusted EBIT. Our
Global Business Units, Advanced Technology Facilities, Biopharma
and Life Sciences, and Data Centers, are well positioned in growth
markets globally. These industries will continue to invest in the
mid- and the long-term. Our goal remains to increase total revenue
to around €10 billion in 2027," comments Peter Schönhofer, CFO
of Exyte.
2023: Further increases in sales and earnings planned
"Between 2018 and 2022 we doubled our sales. For 2023 Exyte
plans to increase sales to close to €8.0 billion. Our leading
market position and our high order backlog of €6.8 billion enable
us to continue to further increase the high level of sales in 2023
and beyond," explains Büchele. Incoming orders are expected to
reach the high level of the previous year. Earnings are supposed to
increase in line with sales development.
"In 2023 we will consistently pursue our growth strategy
'Pathway to Ten' and drive forward our 'Next Level' future agenda
we initiated last year," Büchele continues. With its strategic
focus on industries driven by megatrends and its customer-oriented
strategy, Exyte is in an excellent position to continue its growth
trajectory even in times of economic uncertainties. Schönhofer
adds: "We anticipate the global economy to continue to recover.
However, we still assume that fiscal policy and geopolitical
tensions will continue to have a negative impact on the overall
economic development in 2023."
Business development in 2022 - all segments increased
sales
In 2022 the business segment, Advanced Technology
Facilities, contributed 87 percent of group total sales.
This is due to an increase in sales of 51 percent to
€6.4 billion (2021: €4.2 billion). The ongoing positive
development of investments in the semiconductor industry as well as
the increasing demand for clean- and dryrooms in the context of
battery cell manufacturing had a positive impact on incoming orders
in 2022. Order intake amounted to €6.5 billion. Exyte expects
a constant growth rate in semiconductor and battery cell
manufacturing. The demands for chips and battery cells are rising
continuously. In consequence, companies in these industries will
keep investing billions in new production facilities, also fueled
by government programs and support such as the European Chips Act,
the U.S. CHIPS and Science Act as well as the Inflation Reduction
Act, amongst others. In Germany,
Exyte has built the country's first so called gigafab for battery
cell production for one of the largest battery manufacturers in the
world.
Sales of Biopharma & Life Sciences increased to €610
million in 2022 – 71 percent higher compared to previous year
(2021: €357 million). The order intake grew by 18 percent
to €581 million (2021: €492 million). The segment, accounting
for 8 percent of Exyte's total sales in 2022, is benefitting
from major investments of global pharmaceutical companies,
especially in Asia and
Europe. For example, Exyte started
the construction of a mRNA competence center for a German chemical
company in Halle, Germany. In
Cork, Ireland, Exyte opened a new
Life Sciences Office expecting major business opportunities due to
the rapidly growing Irish pharmaceutical sector. Top players of the
industry are expected to invest billions in the upcoming years as
Ireland is the world's
third-largest net exporter of pharmaceuticals.
Sales in the Data Centers segment reached €288 million,
an increase of 59 percent (2021: €180 million),
while the order intake rose by more than 36 percent to
€415 million (2021: €305 million). In 2022, the data
centers business was mainly driven by projects in Europe and South-East Asia. It focuses on building
energy-efficient computing centers for cloud, high-performance
computing, and co-location service providers. Key clients are large
technology organizations that invest extensively in high-capacity
cloud data centers worldwide. Exyte's Data Centers business also
compromises co-location service providers that offer additional
capacity for scaling for cloud service providers.
Technology & Services consists of entities that
provide cleanroom technology, installation services, and critical
equipment for subsystems of its clients as well as off-site
manufacturing (OSM). Following the acquisition of Critical Process
Systems Group in 2021, Technology & Services in 2022
almost doubled its sales with €775 million (2021:
€427 million), which was around 10 percent[1] of the
group's total sales. The order intake
reached €1.1 billion (2021: €563 million). In 2022
Technology & Services was strengthened by the
strategic acquisition of Airgard Inc., a US based specialist
in exhaust gas cleaning technology. Airgard's wet scrubbers are
used globally by key players in the semiconductor industry. With
this acquisition Exyte strengthened its position to supply
technical solutions for exhaust management, something which is
becoming increasingly important in the context of improving
Environmental, Social and Governance (ESG) performance.
Business development in 2022 – strong sales growth in APAC,
strong order intake growth in AMER
In 2022 the APAC region's sales increased by
145 percent to €4.2 billion year-on-year (2021:
€1.7 billion), whereas the order intake achieved
€4.1 billion (2021: €4.5 billion).
With €2.1 billion (2021: €2.4 billion) EMEA
contributed approximately 28 percent of total sales in 2022.
Order intake amounted to €1.8 billion (2021:
€2.8 billion).
In AMER the order intake rose by 153 percent to
€961 million (2021: €380 million). Sales increased by
32 percent and reached €560 million (2021:
€423 million).
Headcount development in 2022 – continued need for technical
experts
As of December 31, 2022, Exyte
employed some 9,000 employees worldwide. The global workforce has
increased by 20 percent. This growth will continue in 2023, with
Exyte actively recruiting engineers, construction managers and
project managers, amongst others. To enforce this, Exyte launched a
new employer brand in 2022, which will boost global talent
acquisition and recruiting. These measures support Exyte's aim to
reach 15,000 employees by 2027, a doubling of the Exyte workforce
compared to 2021. In various regions Exyte was recognized as a top
employer. In Germany, the company
was named as 'Top Employer 2023' through an audit and evaluation by
the Top Employer Institute. In China, Exyte received the "Pioneer Employer
Award" for the third consecutive year.
"Pathway to Ten" and "Next Level" future agenda for
accelerated profitable growth
2022 marked the beginning of a next level of growth in Exyte's
history. Exyte started its ambitious growth strategy "Pathway to
Ten" and initiated a dedicated future agenda to take the company to
the next level of growth. "Next Level" combines projects and
initiatives in various areas which were pushed forward vigorously
last year. Besides targeted strategic acquisitions, Exyte further
expanded its global footprint in 2022 but at the same time worked
on becoming one global company, by continuing to prioritize the
harmonization and standardization of processes, structures, and
systems worldwide. The goal is not only to foster collaboration
within the company but also to increase efficiency, improve project
delivery as well as customer satisfaction.
[1] Technology & Services is a reporting segment in the
sales statement by region.
Key Financial Figures at a glance
|
|
2022
|
|
2021
|
|
Change
2022 vs.
2021*
|
Order Intake
|
€7.6 bn
|
€8.1 bn
|
-7 %
|
Sales
|
€7.4 bn
|
€4.9 bn
|
+52 %
|
Adjusted
EBITDA
|
€460 m
|
€294 m
|
+56 %
|
Adjusted EBITDA
Margin
|
6.2 %
|
6.0 %
|
+0.2 PP
|
Adjusted
EBIT
|
€416 m
|
€263 m
|
+58 %
|
Adjusted EBIT
Margin
|
5.6 %
|
5.4 %
|
+0.2 PP
|
*The percentage is calculated based on the values in
million.
For more details regarding the 2022 results please visit the
website.
About Exyte
Exyte is a global leader in the design, engineering, and
delivery of ultra-clean and sustainable facilities for high-tech
industries. With cutting-edge expertise developed over more than a
century, the company serves clients in the sophisticated markets of
semiconductors, battery cells, pharmaceuticals, biotechnology, and
data centers. Exyte offers a full range of services from consulting
to managing the implementation of turnkey solutions with the
highest standards in safety and quality to its customers worldwide.
Exyte creates a better future by enabling key industries to enhance
the quality of modern life. In 2022, the company generated sales of
€7.4 billion with around 9,000 employees worldwide.
Contact
René Ziegler
Vice President Corporate Communications & Investor
Relations
+49 711 88044606
+49 172 5838786
rene.ziegler@exyte.net
www.exyte.net
Logo:
https://mma.prnewswire.com/media/1487100/Exyte_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/record-year-exyte-increases-sales-by-52-percent-to-7-4-billion-euros-301781001.html